Search research articles
Contact Us
Filters
Showing results (1-10 of 35) with videos related to
Page
of 4
Sort By:
Current Opinion in Neurology
|
July 15, 2003
Statins as potential therapeutic agents in neuroinflammatory disorders
Olaf Stüve, Sawsan Youssef, Lawrence Steinman, et al.
Blood
|
September 11, 2007
Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activity
Robert Zeiser, Sawsan Youssef, Jeanette Baker, et al.
Immunology
|
February 5, 2009
Regulation of different inflammatory diseases by impacting the mevalonate pathway
Robert Zeiser, Kristina Maas, Sawsan Youssef, et al.
Expert Opinion on Therapeutic Targets
|
September 23, 2003
Statins and their potential targets in multiple sclerosis therapy
Olaf Stüve, Thomas Prod'homme, Anthony Slavin, et al.
Journal of Neuroinflammation
|
February 7, 2014
Neither T-helper type 2 nor Foxp3+ regulatory T cells are necessary for therapeutic benefit of atorvastatin in treatment of central nervous system autoimmunity
Martin S Weber, Thomas Prod'homme, Sawsan Youssef, et al.
Nature Immunology
|
December 5, 2006
Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells
Eun Mi Hur, Sawsan Youssef, M Edward Haws, et al.
Natural Product Research
|
September 11, 2020
Bioactive metabolites of hass and reed avocados targeting methicillin-resistant <i>Staphylococcus aureus</i> enterotoxin-like X via molecular modeling and cytotoxicity assessments
Inas Youssef Younis, Mohamed Saeed Hifnawy, Seham Salaheldin El-Hawary, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 23, 2008
Differential regulation of chemokines by IL-17 in colonic epithelial cells
Jimmy W Lee, Ping Wang, Michael G Kattah, et al.
The Journal of Experimental Medicine
|
February 16, 2006
Isoprenoids determine Th1/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin
Shannon E Dunn, Sawsan Youssef, Matthew J Goldstein, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 24, 2002
Cutting edge: oral type I IFN-tau promotes a Th2 bias and enhances suppression of autoimmune encephalomyelitis by oral glatiramer acetate
Jeanne M Soos, Olaf Stüve, Sawsan Youssef, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 35) with videos related to
Sort By:
Page
of 4
Current Opinion in Neurology
|
July 15, 2003
Statins as potential therapeutic agents in neuroinflammatory disorders
Olaf Stüve, Sawsan Youssef, Lawrence Steinman, et al.
Blood
|
September 11, 2007
Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activity
Robert Zeiser, Sawsan Youssef, Jeanette Baker, et al.
Immunology
|
February 5, 2009
Regulation of different inflammatory diseases by impacting the mevalonate pathway
Robert Zeiser, Kristina Maas, Sawsan Youssef, et al.
Expert Opinion on Therapeutic Targets
|
September 23, 2003
Statins and their potential targets in multiple sclerosis therapy
Olaf Stüve, Thomas Prod'homme, Anthony Slavin, et al.
Journal of Neuroinflammation
|
February 7, 2014
Neither T-helper type 2 nor Foxp3+ regulatory T cells are necessary for therapeutic benefit of atorvastatin in treatment of central nervous system autoimmunity
Martin S Weber, Thomas Prod'homme, Sawsan Youssef, et al.
Nature Immunology
|
December 5, 2006
Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells
Eun Mi Hur, Sawsan Youssef, M Edward Haws, et al.
Natural Product Research
|
September 11, 2020
Bioactive metabolites of hass and reed avocados targeting methicillin-resistant <i>Staphylococcus aureus</i> enterotoxin-like X via molecular modeling and cytotoxicity assessments
Inas Youssef Younis, Mohamed Saeed Hifnawy, Seham Salaheldin El-Hawary, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 23, 2008
Differential regulation of chemokines by IL-17 in colonic epithelial cells
Jimmy W Lee, Ping Wang, Michael G Kattah, et al.
The Journal of Experimental Medicine
|
February 16, 2006
Isoprenoids determine Th1/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin
Shannon E Dunn, Sawsan Youssef, Matthew J Goldstein, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 24, 2002
Cutting edge: oral type I IFN-tau promotes a Th2 bias and enhances suppression of autoimmune encephalomyelitis by oral glatiramer acetate
Jeanne M Soos, Olaf Stüve, Sawsan Youssef, et al.
Page
of 4